GHB
Timeline
| 1920s | GHB is first synthesized. [More Info] | |
| 1960s | GHB is used as an anesthetic & hypnotic on humans in Europe. | |
| 1961 | GHB is first developed by French researcher Dr. Henri Laborit. It was developed for use as an anesthetic but was soon withdrawn due to unwanted side effects. | |
| 1980s | GHB becomes available in health food stores. It gains popularity through its use by body builders who use it as a supplement. | |
| Nov 8, 1990 | FDA bans the over-the-counter sale of GHB for human consumption in the United States. | |
| 1997-1999 | Several countries pass laws to control GHB and many U.S. States place GHB in Schedules I through IV. Some laws include GBL and 1,4Butanediol and others do not. [More Info] | |
| Feb 18, 2000 | President Clinton signed the "Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000" ordering that the attorney general place GHB into Schedule I of the CSA within 60 days. This was done approximately a month later. | |
| Mar 2000 | GHB becomes illegal (schedule I) in the United States with the federal passage of the 'Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000'. | |
| Jul 17, 2002 | The Food and Drug Administration approves GHB (brand name Xyrem, produced Orphan Medical) as a schedule III drug for the treatment of narcolepsy in the small population of patients who experience episodes of cataplexy, a condition characterized by weak or paralyzed muscles. | |
| Jun 27, 2003 | GHB is placed in schedule C in the U.K. |
References
-
No References Found : submitted events list?